5-Fluoro-EPT
Identifiers | |
---|---|
IUPAC name
| |
PubChem CID | |
Chemical and physical data | |
Formula | C15H21FN2 |
Molar mass | 248.345 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
5-Fluoro-EPT (5F-EPT, 5-fluoro-N-ethyl-N-propyltryptamine) is a psychedelic tryptamine derivative related to drugs such as EPT and 5-MeO-EPT. It acts as a potent full agonist at the 5-HT2A receptor with an EC50 of 5.54 nM and an efficacy of 104% (compared to serotonin). It produces a head-twitch response in animal studies, and is claimed to have antidepressant activity.[1]
See also
- 5-Fluoro-AMT
- 5-Fluoro-AET
- 5-Fluoro-DMT
- 5-Fluoro-DET
- 5-Fluoro-MET
References
- ↑ WO 2021/168082, Kruegel AC, Sporn J, "Specific Tryptamines for use in the Treatment of Mood Disorders.", published 26 August 2021, assigned to Gilgamesh Pharmaceuticals, Inc..
|
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.